← All trials
NCT01348217
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2011
- Primary completion
- May 1, 2019
- Completion date
- Feb 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 252
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centre Georges Francois LeclercLead sponsor
- Centre Georges Francois LeclercOverall official - principal investigator
- National Cancer Institute, FranceCollaborator
- UNICANCERCollaborator
- Federation Francophone de Cancerologie DigestiveCollaborator
- French Society of Radiation OncologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.